BRPI0511889A - reprogramação terapêutica, células-tronco hìbridas e maturação - Google Patents
reprogramação terapêutica, células-tronco hìbridas e maturaçãoInfo
- Publication number
- BRPI0511889A BRPI0511889A BRPI0511889-1A BRPI0511889A BRPI0511889A BR PI0511889 A BRPI0511889 A BR PI0511889A BR PI0511889 A BRPI0511889 A BR PI0511889A BR PI0511889 A BRPI0511889 A BR PI0511889A
- Authority
- BR
- Brazil
- Prior art keywords
- cells
- stem cells
- maturation
- therapeutic reprogramming
- therapeutically
- Prior art date
Links
- 230000008672 reprogramming Effects 0.000 title abstract 3
- 210000000130 stem cell Anatomy 0.000 title abstract 3
- 230000001225 therapeutic effect Effects 0.000 title abstract 3
- 230000035800 maturation Effects 0.000 title abstract 2
- 210000004027 cell Anatomy 0.000 abstract 8
- 230000001172 regenerating effect Effects 0.000 abstract 2
- 238000002560 therapeutic procedure Methods 0.000 abstract 2
- 230000001010 compromised effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0608—Germ cells
- C12N5/061—Sperm cells, spermatogonia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/06—Anti-neoplasic drugs, anti-retroviral drugs, e.g. azacytidine, cyclophosphamide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/02—Coculture with; Conditioned medium produced by embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2517/00—Cells related to new breeds of animals
- C12N2517/04—Cells produced using nuclear transfer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2517/00—Cells related to new breeds of animals
- C12N2517/10—Conditioning of cells for in vitro fecondation or nuclear transfer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Reproductive Health (AREA)
- Cardiology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/864,788 US20050090004A1 (en) | 2003-01-16 | 2004-06-08 | Stem cell maturation for all tissue lines |
| US58814604P | 2004-07-15 | 2004-07-15 | |
| PCT/US2005/005052 WO2005123123A2 (en) | 2004-06-08 | 2005-02-16 | Therapeutic reprogramming, hybrid stem cells and maturation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0511889A true BRPI0511889A (pt) | 2008-01-15 |
Family
ID=35355246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0511889-1A BRPI0511889A (pt) | 2004-06-08 | 2005-02-16 | reprogramação terapêutica, células-tronco hìbridas e maturação |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1758989A2 (https=) |
| JP (1) | JP2008501795A (https=) |
| AU (1) | AU2005253923A1 (https=) |
| BR (1) | BRPI0511889A (https=) |
| CA (1) | CA2567692A1 (https=) |
| RU (1) | RU2006147263A (https=) |
| WO (1) | WO2005123123A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090252711A1 (en) * | 2006-05-11 | 2009-10-08 | Andrew Craig Boquest | Stem Cells And Methods Of Making And Using Stem Cells |
| JP5491871B2 (ja) | 2007-02-28 | 2014-05-14 | アドビナス セラピュティックス プライベート リミテッド | グルコキナーゼ活性化因子としての２，２，２−三置換アセトアミド誘導体、その方法及び薬学的応用 |
| EP2155720B1 (en) | 2007-06-08 | 2013-07-17 | Advinus Therapeutics Private Limited | Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application |
| EP2090649A1 (en) | 2008-02-13 | 2009-08-19 | Fondazione Telethon | Method for reprogramming differentiated cells |
| EP2402327B1 (en) | 2010-06-29 | 2018-03-07 | Impetis Biosciences Ltd. | Acetamide compounds as glucokinase activators, their process and medicinal applications |
| EP2796873A1 (en) * | 2013-04-25 | 2014-10-29 | QGel SA | Method for a cell-based drug screening assay and the use thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE382681T1 (de) * | 1998-07-31 | 2008-01-15 | Genzyme Corp | Verbesserung der herzfunktion durch transplantation mesenchymaler stammzellen |
| US20020136709A1 (en) * | 2000-12-12 | 2002-09-26 | Nucleus Remodeling, Inc. | In vitro-derived adult pluripotent stem cells and uses therefor |
| JP2004248505A (ja) * | 2001-09-21 | 2004-09-09 | Norio Nakatsuji | 移植抗原の一部または全てを欠除したｅｓ細胞由来の未分化な体細胞融合細胞およびその製造 |
| CA2474766A1 (en) * | 2002-01-16 | 2003-07-31 | Chauncey Sayre | Stem cell maturation for all tissue types |
| CA2484629A1 (en) * | 2002-05-31 | 2003-12-11 | Apollo Life Sciences Pty Limited | Electrofusion of cells and apparatus therefore |
| AU2003295444A1 (en) * | 2002-11-15 | 2004-06-15 | The Board Of Trustees Of The University Of Illinois | Methods for in vitro expansion of hematopoietic stem cells |
-
2005
- 2005-02-16 EP EP05723204A patent/EP1758989A2/en not_active Withdrawn
- 2005-02-16 WO PCT/US2005/005052 patent/WO2005123123A2/en not_active Ceased
- 2005-02-16 BR BRPI0511889-1A patent/BRPI0511889A/pt not_active IP Right Cessation
- 2005-02-16 JP JP2007527196A patent/JP2008501795A/ja not_active Withdrawn
- 2005-02-16 AU AU2005253923A patent/AU2005253923A1/en not_active Abandoned
- 2005-02-16 RU RU2006147263/14A patent/RU2006147263A/ru unknown
- 2005-02-16 CA CA002567692A patent/CA2567692A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2005253923A1 (en) | 2005-12-29 |
| RU2006147263A (ru) | 2008-07-20 |
| WO2005123123A3 (en) | 2006-03-02 |
| EP1758989A2 (en) | 2007-03-07 |
| WO2005123123A2 (en) | 2005-12-29 |
| CA2567692A1 (en) | 2005-12-29 |
| JP2008501795A (ja) | 2008-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ598176A (en) | Disintegrin variants and pharmaceutical uses thereof | |
| WO2007047766A3 (en) | Methods for rejuvenating cells in vitro and in vivo | |
| WO2005005601A3 (en) | Compositions and methods for treating and diagnosing cancer | |
| MX2009005849A (es) | Composiciones y metodos para tratar cancer con adn rico en cpg y cupredoxinas. | |
| MX2009004238A (es) | Metodos y composiciones para tratamiento de defectos oseos con poblaciones de celulas de placenta. | |
| AU2003285172A8 (en) | Human embryonic stem cell cultures, and compositions and methods for growing same | |
| NZ603330A (en) | Diagnosis and treatment of multiple sulfatase deficiency and other sulfatase deficiencies | |
| WO2008036374A3 (en) | Allogeneic stem cell transplants in non-conditioned recipients | |
| WO2007058850A3 (en) | Inhibitors of akt activity | |
| WO2011098262A3 (en) | P19arf, hmga2 and mdm2 for use in the diagnosis and treatment of aberrant cell growth | |
| MX2007015217A (es) | Sistema automatizado de terapia mediante celulas. | |
| WO2006018836A3 (en) | Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues | |
| EP1536500A4 (en) | ELECTRODE FOR FUEL CELL, FUEL CELL COMPRISING THE ELECTRODE AND METHOD FOR PRODUCING THE ELECTRODE | |
| PT1941027E (pt) | Métodos e meios para proliferação de células estaminais e subsequente geração e expansão de células progenitoras, bem como produção de células efectoras como produtos terapêuticos clínicos | |
| WO2001079164A3 (en) | N-substituted dithiocarbamates for the treatment of biological disorders | |
| IL173369A0 (en) | Pharmaceutical combination of g-csf and plgf useful for blood stem cell | |
| WO2006078782A3 (en) | Compositions containing agm cells and methods of use thereof | |
| BRPI0511889A (pt) | reprogramação terapêutica, células-tronco hìbridas e maturação | |
| TW200716110A (en) | Inhibitors of AKT activity | |
| WO2007028079A3 (en) | Methods of stimulating expansion of hematopoietic stem cells | |
| GB0410130D0 (en) | Cell preparation | |
| TW200510011A (en) | A method for regeneration of bone | |
| WO2006084229A3 (en) | Use of nuclear material to therapeutically reprogram differentiated cells | |
| WO2004070018A3 (en) | Vegf-b and pdgf modulation of stem cells | |
| WO2008021193A3 (en) | Guanosine rich oligonucleotides and methods of inducing apoptosis in tumor cells |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE AS 4A, 5A, 6A E 7A ANUIDADES. |
|
| B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |